comparemela.com

Latest Breaking News On - International prognostic scoring system - Page 6 : comparemela.com

7-Day Dosing of Azacytidine Shows Benefit for Females With High-Risk MDS Not Seen in Males

Investigators from several medical centers in Japan were surprised to find that women with myelodysplastic syndrome (MDS) had a survival advantage from a 7-day dosing schedule, but that benefit compared with a reduced schedule was not seen in men.

Agios Pharma (AGIO) Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946

Agios Pharma (AGIO) Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Higher Leptin Levels, Body Fat Linked to MDS in Study

The authors discussed a polymorphism of the LEP gene associated not only with cancer, but also with chronic diseases including obesity and diabetes, offering them a reason to look into the relationship between LEP and myelodysplastic syndrome (MDS).

Bexmarilimab Plus SOC Continues to Elicit Responses in R/R AML and HMA-Refractory MDS

The addition of bexmarilimab to standard-of-care azacitidine or azacitidine plus venetoclax continued to elicit responses in patients with relapsed or refractory acute myeloid leukemia and those with myelodysplastic syndrome who were refractory to hypomethylating agents.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.